Chronic Venous Occlusion Treatment Market to Hit $10.07B by 2030 at 7.3% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Chronic Venous Occlusions Treatment Market Between 2026 And 2030?
The chronic venous occlusions treatment market size has demonstrated significant growth in recent years. It is projected to increase from $7.15 billion in 2025 to $7.6 billion in 2026, at a compound annual growth rate (CAGR) of 6.3%. Historically, this expansion has been driven by the increasing incidence of venous disorders, broader access to endovascular treatment options, an uptick in hospital-based interventional procedures, greater awareness of chronic venous diseases, and the expanded use of anticoagulant therapies.
The chronic venous occlusions treatment market size is projected to experience robust expansion in the coming years. This market is set to reach $10.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth over the forecast period include an expanding elderly demographic, a heightened demand for outpatient venous interventions, a sharpened focus on timely disease identification, the broader availability of sophisticated imaging-assisted therapies, and the greater uptake of innovative venous devices. Key trends anticipated during the forecast timeframe encompass the wider embrace of minimally invasive venous procedures, the increasing application of advanced venous stenting techniques, a burgeoning inclination towards integrated device and drug treatments, the spread of image-guided endovascular operations, and a stronger emphasis on managing long-term occlusions.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Factors Are Driving The Chronic Venous Occlusions Treatment Market Growth?
The rising occurrence of obesity is projected to fuel the expansion of the chronic venous occlusion treatment market in the future. Obesity, a medical state, is defined by an excessive buildup of body fat, usually leading to a person having a body mass index (BMI) of 30 or greater. Chronic venous occlusion treatment offers assistance in managing symptoms linked to obesity, such as edema and skin alterations, through enhanced blood circulation and decreased inflammation, thereby supporting improved obesity management. As an illustration, data from March 2023, provided by the World Heart Federation, a non-governmental global cardiovascular community based in Switzerland, indicated that approximately 2.3 billion adults and children worldwide were obese or overweight. Furthermore, based on current obesity patterns, projections suggest that the population affected by obesity will increase to 2.7 billion by 2025. Consequently, the expanding prevalence of obesity is stimulating the growth within the chronic venous occlusion treatment market.
Which Segment Classifications Are Used In The Chronic Venous Occlusions Treatment Market Segment Analysis?
The chronic venous occlusions treatment market covered in this report is segmented –
1) By Product: Devices, Drugs
2) By Application: Varicose Veins, Venous Stasis Ulcers, Edema, Deep Vein Thrombosis, Other Applications
3) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Trauma centers, Other End-Users
Subsegments:
1) By Devices: Venous Stents, Catheters, Endovenous Laser Therapy (EVLT) Devices, Angioplasty Balloons
2) By Drugs: Anticoagulants, Thrombolytics, Anti-inflammatory Medications, Pain Management Drugs
Which Trends Are Guiding The Direction Of The Chronic Venous Occlusions Treatment Market?
Companies operating in the chronic venous occlusion treatment market are concentrating on creating advanced solutions, including implantable medical devices designed to address symptomatic venous outflow obstruction in individuals with chronic venous insufficiency (CVI). An implantable medical device is a surgically inserted product meant to stay within the body for prolonged periods, typically to diagnose, treat, or monitor health issues. For example, in June 2024, Koninklijke Philips N.V. (Philips), a Netherlands-based technology firm, introduced the Duo Venous Stent System, which is an implantable medical device. This Duo Venous Stent System from Koninklijke Philips N.V. incorporates a dual-layer structure to improve flexibility and radial strength for superior vein support. Its sophisticated coating enhances biocompatibility and reduces the chance of thrombosis, while a precise delivery system guarantees accurate positioning even in complex anatomical areas.
Which Firms Are Contributing To The Chronic Venous Occlusions Treatment Market Ecosystem?
Major companies operating in the chronic venous occlusions treatment market are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA
Get The Full Chronic Venous Occlusions Treatment Market Report:
Which Region Accounts For The Largest Portion Of The Chronic Venous Occlusions Treatment Market?
North America was the largest region in the chronic venous occlusions treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Chronic Venous Occlusions Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Chronic Venous Occlusions Treatment Market 2026, By The Business Research Company
Bleeding Disorders Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
Retinal Vein Occlusion Treatment Market Report 2026
Retinal Vein Occlusion Market Report 2026
https://www.thebusinessresearchcompany.com/report/retinal-vein-occlusion-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
